Compare PURR & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PURR | ATEC |
|---|---|---|
| Founded | 2025 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2025 | 2006 |
| Metric | PURR | ATEC |
|---|---|---|
| Price | $6.68 | $9.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | $8.15 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 7.4M | 2.3M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.04 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $101,739,000.00 |
| Revenue This Year | N/A | $18.97 |
| Revenue Next Year | $148.78 | $16.70 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.01 | $6.82 |
| 52 Week High | $11.73 | $23.29 |
| Indicator | PURR | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 45.79 | 58.48 |
| Support Level | $5.75 | $8.06 |
| Resistance Level | $6.87 | $10.39 |
| Average True Range (ATR) | 0.33 | 0.43 |
| MACD | 0.09 | 0.02 |
| Stochastic Oscillator | 67.83 | 64.09 |
Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. HSI aims to provide capital-efficient and productive access to the HYPE token for U.S. and institutional investors, generating compounding shareholder returns that individual holders may not be able to replicate through staking, yield optimization, and active ecosystem engagement. HSI is positioned to become the largest HYPE-focused digital asset treasury vehicle capitalizing on Hyperliquid's rapid growth and providing exposure to one of the largest and fastest growing revenue pools in digital assets.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.